Tyrosine kinase inhibitor

Explore academic connections and research related to this keyword

273
Views
106
Total Connections

Related Articles & Bibliographies

1
The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations.
Soysal, Teoman;Eskazan, Ahmet Emre;Serin, Istemi;Sadri, Sevil;Keskin, Dilek;Ozgur Yurttas, Nurgul;Be...
2019 clinical lymphoma, myeloma & leukemia DOI: S2152-2650(18)31616-... 254 views
2
Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.
Eskazan, Ahmet Emre;Keskin, Dilek;
2017 Therapeutic advances in hematology DOI: 10.1177/204062071771... 235 views
3
Potential tripeptides against the tyrosine kinase domain of human epidermal growth factor receptor (HER) 2 through computational and kinase assay approaches.
Seetaha, Supaphorn;Boonyarit, Bundit;Tongsima, Sissades;Songtawee, Napat;Choowongkomon, Kiattawee;
2020 journal of molecular graphics & modelling DOI: S1093-3263(19)30580-... 201 views
5
tyrosine kinase inhibitor induced isolated pericardial effusion
;Vineet Agrawal;Eric S. Christenson;Margaret M. Showel
2015 multi-span large bridges - proceedings of the inte... DOI: 10.1159/000375484 152 views
6
Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors.
Karakulak, Ugur Nadir;Aladag, Elifcan;Hekimsoy, Vedat;Sahiner, Mehmet Levent;Kaya, Ergun Baris;Ozer,...
2021 Cardiovascular toxicology DOI: 10.1007/s12012-020-0... 195 views
7
Pathogenic impact of transcript isoform switching in 1,209 cancer samples covering 27 cancer types using an isoform-specific interaction network.
Kahraman, Abdullah;Karakulak, Tülay;Szklarczyk, Damian;von Mering, Christian;
2020 Scientific reports DOI: 10.1038/s41598-020-7... 118 views
8
Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors.
Wei, Huiqiang;Duan, Yuqing;Gou, Wenfeng;Cui, Jie;Ning, Hongxin;Li, Deguan;Qin, Yong;Liu, Qiang;Li, Y...
2019 European journal of medicinal chemistry DOI: S0223-5234(19)30676-... 285 views
9
Afatinib for the treatment of metastatic non-small cell lung cancer
Monika Joshi;Syed M Rizvi;Chandra P Belani and
2015 Cancer management and research DOI: 10.2147/CMAR.S51808 399 views
10
Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
Jörg Trojan;Oliver Waidmann and
2016 journal of hepatocellular carcinoma DOI: 10.2147/JHC.S112537 249 views
11
Afatinib for the treatment of metastatic non-small cell lung cancer
2015 Cancer management and research DOI: 10.2147/CMAR.S51808 354 views
12
Afatinib for the treatment of metastatic non-small cell lung cancer
Monika Joshi;Syed M Rizvi;Chandra P Belani;
2015 Cancer management and research DOI: 10.2147/CMAR.S51808 354 views
13
Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
Jörg Trojan;Oliver Waidmann;
2016 journal of hepatocellular carcinoma DOI: 10.2147/JHC.S112537 219 views
14
Haematological adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukaemia: A network meta-analysis.
Fachi, Mariana M;Tonin, Fernanda S;Leonart, Leticia P;Rotta, Inajara;Fernandez-Llimos, Fernando;Pont...
2019 British journal of clinical pharmacology DOI: 10.1111/bcp.13933 290 views
15
Poly(Cyclohexene Phthalate) Nanoparticles for Controlled Dasatinib Delivery in Breast Cancer Therapy.
Niza, Enrique;Nieto-Jiménez, Cristina;Noblejas-López, María Del Mar;Bravo, Iván;Castro-Osma, José An...
2019 Nanomaterials (Basel, Switzerland) DOI: E1208 175 views
16
Systematic Review on Cytotoxic and Anticancer Potential of N-Substituted Isatins as Novel Class of Compounds Useful in Multidrug-Resistant Cancer Therapy: In Silico and In Vitro Analysis.
Gupta, Alpana K;Tulsyan, Sonam;Bharadwaj, Mausumi;Mehrotra, Ravi;
2019 topics in current chemistry (cham) DOI: 10.1007/s41061-019-0... 286 views
17
Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels.
Al-Ishaq, Raghad Khalid;Abotaleb, Mariam;Kubatka, Peter;Kajo, Karol;Büsselberg, Dietrich;
2019 Biomolecules DOI: E430 297 views
18
Structural characterization of EGFR exon 19 deletion mutation using molecular dynamics simulation.
Tamirat, Mahlet Z;Koivu, Marika;Elenius, Klaus;Johnson, Mark S;
2019 PloS one DOI: 10.1371/journal.pone... 306 views
21
Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial.
Neal, Joel W;Dahlberg, Suzanne E;Wakelee, Heather A;Aisner, Seena C;Bowden, Michaela;Huang, Ying;Car...
2016 the lancet oncology DOI: S1470-2045(16)30561-... 243 views
22
Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells.
Takenaka, Tomoya;Nakai, Shinya;Katayama, Miku;Hirano, Mami;Ueno, Natsumi;Noguchi, Kosuke;Takatani-Na...
2019 International journal of pharmaceutics DOI: S0378-5173(19)30807-... 270 views

Related Journals

Scientific reports
ISSN: 2045-2322 588 views
clinical lymphoma, myeloma & leukemia
ISSN: 2152-2669 285 views
Therapeutic advances in hematology
ISSN: 2040-6207 430 views
Cardiovascular toxicology
ISSN: 1530-7905 161 views

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.